Intest Res.  2014 Jul;12(3):173-175. 10.5217/ir.2014.12.3.173.

Crohn's Disease Clinical Network and Cohort (CONNECT) Study: The First Step Toward Nationwide Multicenter Research of Crohn's Disease in Korea

Affiliations
  • 1Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
  • 2Department of Internal Medicine, Inje University College of Medicine, Seoul, Korea.
  • 3Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea.
  • 4Department of Internal Medicine, Catholic University College of Medicine, Suwon, Korea.
  • 5Department of Internal Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • 6Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea. jooskim@snu.ac.kr
  • 7Department of Internal Medicine, Hanyang University College of Medicine, Guri, Korea. hands@hanyang.ac.kr

Abstract

No abstract available.


MeSH Terms

Cohort Studies*
Crohn Disease*
Korea

Figure

  • Fig. 1 The progress of 3 studies integrated into the Crohn's Disease Clinical Network and Cohort (CONNECT) study. KASID, Korean Association for the Study of Intestinal Diseases.


Cited by  5 articles

Second Korean Guidelines for the Management of Crohn's Disease
Jae Jun Park, Suk-Kyun Yang, Byong Duk Ye, Jong Wook Kim, Dong Il Park, Hyuk Yoon, Jong Pil Im, Kang Moon Lee, Sang Nam Yoon, Heeyoung Lee,
Korean J Gastroenterol. 2017;69(1):29-54.    doi: 10.4166/kjg.2017.69.1.29.

Iranian Registry of Crohn’s and Colitis: study profile of first nation-wide inflammatory bowel disease registry in Middle East
Masoud M Malekzadeh, Alireza Sima, Sudabeh Alatab, Anahita Sadeghi, Nasser Ebrahimi Daryani, Payman Adibi, Iradj Maleki, Hassan Vossoughinia, Hafez Fakheri, Abbas Yazdanbod, Seyed Alireza Taghavi, Rahim Aghazadeh, Mohammad Hassan Somi, Kazem Zendedel, Homayoon Vahedi, Reza Malekzadeh
Intest Res. 2019;17(3):330-339.    doi: 10.5217/ir.2018.00157.

Second Korean guidelines for the management of Crohn's disease
Jae Jun Park, Suk-Kyun Yang, Byong Duk Ye, Jong Wook Kim, Dong Il Park, Hyuk Yoon, Jong Pil Im, Kang Moon Lee, Sang Nam Yoon, Heeyoung Lee,
Intest Res. 2017;15(1):38-67.    doi: 10.5217/ir.2017.15.1.38.

Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future
Jung Won Lee, Jong Pil Im, Jae Hee Cheon, You Sun Kim, Joo Sung Kim, Dong Soo Han
Intest Res. 2015;13(3):213-218.    doi: 10.5217/ir.2015.13.3.213.

Institutional Board Review for Clinical Investigations on Inflammatory Bowel Diseases: A Single-Center Study
Sinyoung Park, Yang Hee Noh, Sun Young Rha, Won Ho Kim, Jae Hee Cheon
Intest Res. 2015;13(3):274-281.    doi: 10.5217/ir.2015.13.3.274.


Reference

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007; 448:427–434. PMID: 17653185.
Article
2. Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008; 103:3167–3182. PMID: 19086963.
Article
3. Cheon JH. Genetics of inflammatory bowel diseases: a comparison between Western and Eastern perspectives. J Gastroenterol Hepatol. 2013; 28:220–226. PMID: 23189979.
Article
4. Kim ES, Kim WH. Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics. Gut Liver. 2010; 4:1–14. PMID: 20479907.
Article
5. Solberg IC, Cvancarova M, Vatn MH, Moum B. Risk matrix for prediction of advanced disease in a population-based study of patients with Crohn's disease (the IBSEN Study). Inflamm Bowel Dis. 2014; 20:60–68. PMID: 24280875.
Article
6. Clara I, Lix LM, Walker JR, et al. The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity. Am J Gastroenterol. 2009; 104:1754–1763. PMID: 19455122.
Article
7. Jess T, Loftus EV Jr, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology. 2006; 130:1039–1046. PMID: 16618397.
Article
8. Kim BJ, Choi YS, Jang BI, et al. Prospective evaluation of the clinical utility of interferon-gamma assay in the differential diagnosis of intestinal tuberculosis and Crohn's disease. Inflamm Bowel Dis. 2011; 17:1308–1313. PMID: 21053248.
Article
9. Kim YS, Kim YH, Kim WH, et al. Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-gamma assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis. Clin Chim Acta. 2011; 412:1527–1532. PMID: 21575618.
Article
10. Ye BD, Yang SK, Shin SJ, et al. Guidelines for the management of Crohn's disease. Intest Res. 2012; 10:26–66.
Article
11. Ye BD, Jang BI, Jeen YT, Lee KM, Kim JS, Yang SK. Diagnostic guideline of Crohn's disease. Korean J Gastroenterol. 2009; 53:161–176. PMID: 19835218.
12. Kim YS, Kim YH, Lee KM, Kim JS, Park YS. Diagnostic guideline of intestinal tuberculosis. Korean J Gastroenterol. 2009; 53:177–186. PMID: 19835219.
13. Park SJ, Cheon JH, Ye BD, et al. A survey of actual clinical application patterns in Korean diagnostic guidelines for inflammatory bowel disease. Korean J Gastroenterol. 2012; 60:292–299. PMID: 23172277.
Article
Full Text Links
  • IR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr